UROTHELIAL CARCINOMA RECURRENT
Clinical trials for UROTHELIAL CARCINOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA RECURRENT trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to shrink bladder tumors before surgery
Disease control CompletedThis study tested if taking a pill called pemigatinib for 4-6 weeks before standard tumor-removal surgery could help treat recurrent, early-stage bladder cancer. It involved 30 adults whose cancer had returned but was still considered low or intermediate risk. The main goal was t…
Matched conditions: UROTHELIAL CARCINOMA RECURRENT
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
New bladder cancer drug tested for safety in early trial
Disease control CompletedThis early-stage study tested the safety of a new drug called UGN-301 for people with recurring non-muscle invasive bladder cancer. The drug was delivered directly into the bladder, both by itself and combined with other treatments. The main goal was to find a safe dose and under…
Matched conditions: UROTHELIAL CARCINOMA RECURRENT
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC